Pharmaceuticals is a specialty pharmaceutical company developing non-invasive, topically delivered products. Its innovative and patented Accudel cream formulation technology is designed to enable highly-targeted, site-specific treatment. Its lead drug candidate, Imprimis – a topical, non-steroidal anti-inflammatory cream – is expected to enter Phase 3 clinical trials in early 2013.
The company’s drug development strategy calls for repurposing or reformatting existing FDA-approved generic drugs to create new high-value, FDA-approved manufactured drugs that address new therapeutic applications. In other words, generic drugs would be combined with Imprimis’ technology to create brand new medications targeted at markets with a specific need.
Imprimis today announced a strategic investment and development agreement with Professional Compounding Centers of America (PCCA). This company provides a variety of products and services to its member compounding pharmacies and works directly with prescribers to provide patients with specialized medications that are normally not available over-the-counter or by prescription. It has also led in the research and development of topical and transdermal technology, including its Lipoderm family of topical bases – the industry’s only bases proven to deliver four drugs at once.
The proposed agreement will allow the two companies to develop and share drug formulation technology with the goal of creating a new generation of treatments for muscle and joint pain, neuropathic pain, and other conditions. PCCA also made a $4 million equity investment into Imprimis. The agreement gives Imprimis exclusive non-PCCA-member access to PCCA’s topical technologies and formulation know-how for delivering drugs directly through the skin.
To learn more about Imprimis Pharmaceuticals, visit www.imprimispharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment